Press Releases

Date Title and Summary
Toggle Summary Technische Universität München Hospital is First in Germany to Treat Cancer Patients with Accuray Radixact® System
Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care SUNNYVALE, Calif. , Oct. 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Klinikum rechts der Isar der Technischen Universität München (TUM) clinical team has treated the
Toggle Summary HCG is First in India to Treat Cancer Patients Using the Accuray Radixact® System
Adoption of Innovative Radiation Therapy Technology Reinforces South Asian Cancer Center's Position as Pioneer in Patient Care SUNNYVALE, Calif. , Oct. 4, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the clinical team at Healthcare Global Enterprises (HCG) EKO,
Toggle Summary Largest Prostate SBRT Studies to Date Show Accuray CyberKnife® System Provides Excellent Prostate Cancer Survival Rates in Five or Fewer Sessions
Recently Published Data Demonstrate Benefits of CyberKnife Treatment for Both Low- and Intermediate-Risk Patients at Five Years Post-Treatment SUNNYVALE, Calif. , Sept. 25, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that published data from two prospective,
Toggle Summary Accuray Reports Fourth Quarter and Fiscal 2018 Financial Results
SUNNYVALE, Calif. , Aug. 16, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2018 . Q4 Fiscal 2018 and Recent Operating Highlights Gross orders increased 12 percent to $96.4 million Revenue increased to
Toggle Summary Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System
Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System SUNNYVALE, Calif. , July 25, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that the Addenbrooke's Hospital clinical team has treated the first
Toggle Summary Joseph E. Whitters Appointed to Accuray Board of Directors
SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company's Board of Directors, effective as of July 16, 2018 . In addition, he will serve on the Board's Audit Committee. With Mr.
Toggle Summary Accuray To Report Fiscal 2018 Fourth Quarter And Full Year Financial Results On August 16, 2018
SUNNYVALE, Calif. , July 19, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report results for its fourth quarter and fiscal year 2018 ended June 30, 2018 on Thursday, August 16, 2018 after the market close. Management will host a conference call to review the fourth quarter results
Toggle Summary Accuray Receives AERB Approval for Sale and Supply of its Radixact® X9 System in India
SUNNYVALE, Calif. , June 21, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the Company has received an Atomic Energy Regulatory Board (AERB) Type Approval for its Radixact ® X9 System in India . The AERB Type Approval indicates the device conforms to established
Toggle Summary New Studies Show the Accuray TomoTherapy® System Provides Greater Precision, Excellent Clinical Outcomes in Patients Undergoing Total Body Irradiation
SUNNYVALE, Calif. , May 30, 2018 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that recently published data from two new studies demonstrate the benefits of the TomoTherapy ® System in the delivery of total body irradiation (TBI), a procedure commonly used to prepare patients
Toggle Summary Accuray CyberKnife® Customer Achieves Top Score in Multiple Brain Metastases TROG 2018 Treatment Plan Study
- Results Demonstrate Exceptional Treatment Plan Quality Achievable with Accuray Treatment Planning Software (TPS) - Renowned Clinical Trials Group TROG Cancer Research and ProKnow Partnered to Host Study SUNNYVALE, Calif. , May 22, 2018 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY)